Trading Signals: ADAP Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Fri. May. 28, 2021)(Adaptimmune Therapeutics plc)
| ADAP latest price $5.0550 (-0.69%) ($5.0550 - $5.0550) on Thu. Apr. 15, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.32% (three month average) | RSI | 46 | Latest Price | $5.0550(-0.69%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ADAP declines -0.4% a day on average for past five trading days. | Weekly Trend | ADAP declines -1.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ADAP advance at 0% a week (0% probability) VYM(69%) SDY(45%) XLU(40%) XLP(49%) SPLV(47%) | Factors Impacting ADAP price | ADAP will decline at least -2.16% in a week (0% probabilities). XRT(18%) ICLN(-14%) JETS(-15%) IWO(-7%) IWM(2%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.16% (StdDev 4.32%) | Hourly BBV | 0.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-3.27(-164.69%) | Inflection Point | Yes | Resistance Level | $5.19 | 5 Day Moving Average | $5.04(0.3%) | 10 Day Moving Average | $5.16(-2.03%) | 20 Day Moving Average | $5.19(-2.6%) | To recent high | -26.1% | To recent low | 0.6% | Market Cap | $782m | | | | Adaptimmune Therapeutics Plc engages in the development of novel cancer immunotherapy products. Its specific peptide enhanced affinity receptor platform enables the engineering of T-cells to target and destroy cancer, including solid tumors. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin in 2008 and is headquartered in Abingdon, the United Kingdom. |